Kaufman Jonathan's most recent trade in Lipella Pharmaceuticals Inc was a trade of 536,959 Series C Voting Convertible Preferred Stock done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Apr 2025 | 536,959 | 0 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Apr 2025 | 125,833 | 0 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Apr 2025 | 28,924 | 0 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Apr 2025 | 4,060 | 0 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Mar 2025 | 10,326 | 536,959 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Mar 2025 | 4,060 | 4,060 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 84,700 | 526,633 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 28,924 | 28,924 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 441,933 | 441,933 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 125,833 | 125,833 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Jan 2025 | 303,041 | 0 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Jan 2025 | 85,421 | 0 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Jan 2025 | 11,795 | 0 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 42,933 | 303,041 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 11,795 | 11,795 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Kaufman Jonathan | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2024 | 260,108 | 260,108 | - | - | Series C Voting Convertible Preferred Stock | |
| Lipella Pharmaceuticals Inc | Kaufman Jonathan | Director, See remarks below., Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2024 | 85,421 | 85,421 | - | - | Common Stock Purchase Warrants | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.76 per share. | 14 May 2024 | 10,000 | 898,849 | - | 0.8 | 7,590 | Common Stock |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 80,000 | 80,000 | - | - | Stock Options | |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 15 Mar 2024 | 30,000 | 863,849 | - | 0.8 | 23,649 | Common Stock |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 15 Mar 2024 | 25,000 | 888,849 | - | 0.9 | 21,803 | Common Stock |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.69 per share. | 13 Mar 2024 | 144,906 | 833,849 | - | 0.7 | 100,000 | Common Stock |
| Lipella Pharmaceuticals Inc | Jonathan Kaufman | Director, See remarks below., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 79,500 | 79,500 | - | - | Stock Options |